Global Cord Blood Corporation

CORBFOTCHealthcare● Active

$0.95

+$0.00(+0.00%)

Market Cap$127218975

P/E Ratio—

52W High$1.75

52W Low$0.2

Avg Volume13K

Open$0.95

Beta-0.77

Earnings Financials Revenue

Global Cord Blood Corporation (CORBF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

CORBF · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2024	Apr 15, 2024	—	—	—	—	$0.04B	—
◌ Q1 FY2024	Mar 1, 2024	—	—	—	—	—	—
◌ Q4 FY2023	Nov 14, 2023	—	—	—	—	—	—
◌ Q3 FY2023	Aug 8, 2023	—	—	—	—	—	—
◌ Q1 FY2023	Mar 2, 2023	—	—	—	—	—	—

Q2 FY2024

Apr 15, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Mar 1, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2023

Nov 14, 2023

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2023

Aug 8, 2023

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2023

Mar 2, 2023

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q1 FY2025	$0.85	$0.85	$0.85	1
Q4 FY2024	$0.82	$0.82	$0.82	1
Q2 FY2019	$0.78	$0.78	$0.78	1
Q4 FY2018	$0.00	$0.00	$0.00	0
Q3 FY2018	$0.00	$0.00	$0.00	0

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q1 FY2025	$0.3B	$0.3B	$0.3B	1
Q4 FY2024	$0.3B	$0.3B	$0.3B	1
Q2 FY2019	$0.3B	$0.3B	$0.3B	1
Q4 FY2018	$0.3B	$0.3B	$0.3B	1
Q3 FY2018	$0.3B	$0.3B	$0.3B	1

About Earnings & Data Methodology

Global Cord Blood Corporation (CORBF) reports earnings quarterly as a OTC-listed Medical - Diagnostics & Research company. The next CORBF earnings date is expected around September 1, 2026.

Each quarter, investors track CORBF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CORBF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

CORBF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

CORBF earnings · 3 questions

Global Cord Blood Corporation's next earnings report is expected around September 1, 2026. CORBF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CORBF historically reports after market close (AMC).

CORBF earnings datewhen is CORBF earningsCORBF next earnings datewhen does CORBF report earningsCORBF earnings calendar

▸ Source: FMP · Global Cord Blood Corporation SEC filings · US GAAP · Global Cord Blood Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026